4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-25-016219
Options or other derivatives
- Director acquired 16,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| CONRAD HERBERT J Director | 2025-06-05 | Grant or award · Non-Qualified Stock Option (right to buy) | +16,500 | 16,500 | D | ||
Loading xslF345X05/form4-06092025_080631.xml…